Telomir Pharmaceuticals, Inc. (TELO) SEC filings
TELO SEC filings moved a median of -1.75% by the close. TELO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TELO overview →
83 measured TELO SEC filing events.
Where these TELO SEC filings landedvs 82 measured TELO SEC filing reactions
| Middle 50% of TELO SEC filing reactions | -5.43% to +2.99% |
|---|---|
| Median reaction (to close) | -1.75% |
| Measured reactions | 82 |
Point-in-time · zero look-ahead
Half of the 82 TELO SEC filing events with a measured close landed between -5.43% and +2.99%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Telomir Pharmaceuticals, For: Oct 05 | SEC filing · Form 8-K | +0.80% | -4.00% | |
| Form 8-K Telomir Pharmaceuticals, For: Sep 17 | SEC filing · Form 8-K | +0.00% | -5.08% | |
| Form 8-K Telomir Pharmaceuticals, For: Sep 11 | SEC filing · Form 8-K | +0.00% | -5.08% | |
| Form 8-K Telomir Pharmaceuticals, For: Sep 14 | SEC filing · Form 8-K | -0.45% | +4.46% | |
| Form DEFA14A Telomir Pharmaceuticals, | SEC filing · Form DEFA14A | — | +8.33% | |
| Form 10-Q Telomir Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.68% | +2.83% | |
| Form 8-K Telomir Pharmaceuticals, For: Aug 10 | SEC filing · Form 8-K | +0.00% | — | |
| Form DEF 14A Telomir Pharmaceuticals, For: Jul 28 | SEC filing · Form DEF | +0.00% | +4.31% | |
| Form 8-K Telomir Pharmaceuticals, For: Jun 15 | SEC filing · Form 8-K | +4.07% | +4.88% | |
| Form 8-K Telomir Pharmaceuticals, For: Jun 03 | SEC filing · Form 8-K | +0.00% | -5.47% | |
| Form 8-K Telomir Pharmaceuticals, For: May 20 | SEC filing · Form 8-K | +0.41% | +7.38% | |
| Form 10-Q Telomir Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | -0.39% | |
| Form 8-K Telomir Pharmaceuticals, For: Apr 24 | SEC filing · Form 8-K | -7.35% | -4.76% | |
| Form 8-K Telomir Pharmaceuticals, For: Apr 22 | SEC filing · Form 8-K | -1.44% | +0.72% | |
| Form 8-K Telomir Pharmaceuticals, For: Mar 30 | SEC filing · Form 8-K | +1.64% | +10.17% | |
| Form 8-K Telomir Pharmaceuticals, For: Mar 31 | SEC filing · Form 8-K | +1.64% | +10.17% | |
| Form 8-K Telomir Pharmaceuticals, For: Mar 23 | SEC filing · Form 8-K | -0.56% | -8.06% | |
| Form 10-K Telomir Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.76% | -3.79% | |
| Form DEFA14A Telomir Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +0.89% | |
| Form DEFM14A Telomir Pharmaceuticals, | SEC filing · Form DEFM14A | +0.00% | +0.89% | |
| Form 8-K Telomir Pharmaceuticals, For: Feb 17 | SEC filing · Form 8-K | -1.79% | +2.68% | |
| Form 8-K Telomir Pharmaceuticals, For: Feb 05 | SEC filing · Form 8-K | -1.71% | -4.27% | |
| Form PRER14A Telomir Pharmaceuticals, | SEC filing · Form PRER14A | -1.71% | -4.27% | |
| Form PRER14A Telomir Pharmaceuticals, | SEC filing · Form PRER14A | +0.37% | -1.49% | |
| Form 8-K Telomir Pharmaceuticals, For: Jan 08 | SEC filing · Form 8-K | — | -0.04% | |
| Form 8-K Telomir Pharmaceuticals, For: Jan 05 | SEC filing · Form 8-K | +0.73% | +8.76% | |
| Form 8-K Telomir Pharmaceuticals, For: Dec 17 | SEC filing · Form 8-K | +1.43% | +2.14% | |
| Form 8-K Telomir Pharmaceuticals, For: Dec 17 | SEC filing · Form 8-K | -1.44% | -1.44% | |
| Form PRER14A Telomir Pharmaceuticals, | SEC filing · Form PRER14A | +0.00% | -1.53% | |
| Form 8-K Telomir Pharmaceuticals, For: Nov 24 | SEC filing · Form 8-K | +0.00% | +3.15% | |
| Form 8-K Telomir Pharmaceuticals, For: Nov 14 | SEC filing · Form 8-K | -3.89% | -10.49% | |
| Form 8-K Telomir Pharmaceuticals, For: Nov 20 | SEC filing · Form 8-K | -3.89% | -10.49% | |
| Form PREM14A Telomir Pharmaceuticals, For: Nov 20 | SEC filing · Form PREM14A | -3.89% | -10.49% | |
| Form 8-K Telomir Pharmaceuticals, For: Nov 12 | SEC filing · Form 8-K | +3.58% | -3.57% | |
| Form 10-Q Telomir Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.45% | +5.97% | |
| Form 8-K Telomir Pharmaceuticals, For: Oct 22 | SEC filing · Form 8-K | +2.41% | +6.47% | |
| Form 8-K Telomir Pharmaceuticals, For: Oct 17 | SEC filing · Form 8-K | +2.45% | -7.97% | |
| Form 8-K Telomir Pharmaceuticals, For: Oct 14 | SEC filing · Form 8-K | -3.43% | -6.29% | |
| Form 8-K Telomir Pharmaceuticals, For: Oct 08 | SEC filing · Form 8-K | -2.50% | -3.98% | |
| Form 8-K Telomir Pharmaceuticals, For: Oct 06 | SEC filing · Form 8-K | -2.84% | +3.45% | |
| Form 8-K Telomir Pharmaceuticals, For: Sep 18 | SEC filing · Form 8-K | +1.27% | +6.06% | |
| Form 8-K Telomir Pharmaceuticals, For: Sep 09 | SEC filing · Form 8-K | +1.59% | +7.94% | |
| Form 8-K Telomir Pharmaceuticals, For: Aug 28 | SEC filing · Form 8-K | +4.37% | +1.22% | |
| Form 8-K Telomir Pharmaceuticals, For: Aug 27 | SEC filing · Form 8-K | -8.94% | -28.50% | |
| Form 10-Q Telomir Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.40% | -1.97% | |
| Form 8-K Telomir Pharmaceuticals, For: Aug 07 | SEC filing · Form 8-K | -2.25% | -9.73% | |
| Form 8-K Telomir Pharmaceuticals, For: Jul 23 | SEC filing · Form 8-K | +0.98% | +12.26% | |
| Form 8-K Telomir Pharmaceuticals, For: Jul 18 | SEC filing · Form 8-K | -1.46% | +0.00% | |
| Form 8-K Telomir Pharmaceuticals, For: Jul 17 | SEC filing · Form 8-K | -12.58% | -26.45% | |
| Form 8-K Telomir Pharmaceuticals, For: Jun 18 | SEC filing · Form 8-K | -1.05% | -6.88% | |
| Form 8-K Telomir Pharmaceuticals, For: Jun 11 | SEC filing · Form 8-K | +0.24% | -3.43% | |
| Form 8-K Telomir Pharmaceuticals, For: Jun 05 | SEC filing · Form 8-K | -4.76% | -4.29% | |
| Form 8-K Telomir Pharmaceuticals, For: Jun 02 | SEC filing · Form 8-K | -1.51% | +6.06% | |
| Form 8-K Telomir Pharmaceuticals, For: May 29 | SEC filing · Form 8-K | +0.98% | +2.94% | |
| Form 8-K Telomir Pharmaceuticals, For: May 15 | SEC filing · Form 8-K | -1.86% | +3.29% | |
| Form 8-K Telomir Pharmaceuticals, For: May 19 | SEC filing · Form 8-K | +0.65% | -7.39% | |
| Form 8-K Telomir Pharmaceuticals, For: May 15 | SEC filing · Form 8-K | +2.62% | -11.61% | |
| Form 10-Q Telomir Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.62% | -11.61% | |
| Form 8-K Telomir Pharmaceuticals, For: May 07 | SEC filing · Form 8-K | +1.20% | -0.80% | |
| Form 8-K Telomir Pharmaceuticals, For: Mar 19 | SEC filing · Form 8-K | -2.38% | +3.57% | |
| Form EFFECT Telomir Pharmaceuticals, | SEC filing · Form EFFECT | +1.18% | +3.01% | |
| Form 8-K Telomir Pharmaceuticals, For: Feb 25 | SEC filing · Form 8-K | +0.48% | -0.96% | |
| Form 8-K Telomir Pharmaceuticals, For: Feb 20 | SEC filing · Form 8-K | -1.19% | -7.13% | |
| Form 8-K Telomir Pharmaceuticals, For: Feb 18 | SEC filing · Form 8-K | -2.38% | -6.67% | |
| Form S-3 Telomir Pharmaceuticals, | SEC filing · Form S-3 | -2.38% | -6.67% | |
| Form 10-K Telomir Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.33% | |
| Form 8-K Telomir Pharmaceuticals, For: Jan 28 | SEC filing · Form 8-K | +0.81% | -1.28% | |
| Form 8-K Telomir Pharmaceuticals, For: Jan 07 | SEC filing · Form 8-K | -0.22% | +1.11% | |
| Form 8-K Telomir Pharmaceuticals, For: Dec 23 | SEC filing · Form 8-K | +4.60% | -2.51% | |
| Form 8-K Telomir Pharmaceuticals, For: Dec 16 | SEC filing · Form 8-K | +4.60% | -2.51% | |
| Form 8-K Telomir Pharmaceuticals, For: Dec 09 | SEC filing · Form 8-K | -1.59% | -5.04% | |
| Form 8-K Telomir Pharmaceuticals, For: Dec 02 | SEC filing · Form 8-K | +0.00% | +8.69% | |
| Form 8-K Telomir Pharmaceuticals, For: Nov 18 | SEC filing · Form 8-K | -8.78% | -13.47% | |
| Form 8-K Telomir Pharmaceuticals, For: Nov 20 | SEC filing · Form 8-K | +5.59% | +0.00% | |
| Form 10-Q Telomir Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.24% | -2.93% | |
| Form 8-K Telomir Pharmaceuticals, For: Sep 27 | SEC filing · Form 8-K | +0.15% | -4.89% | |
| Form 8-K Telomir Pharmaceuticals, For: Sep 03 | SEC filing · Form 8-K | +0.00% | -5.74% | |
| Form 10-Q Telomir Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -5.88% | -10.35% | |
| Form 8-K Telomir Pharmaceuticals, For: Jun 18 | SEC filing · Form 8-K | — | -4.54% | |
| Form 10-Q Telomir Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | -5.90% | |
| Form 8-K Telomir Pharmaceuticals, For: Apr 15 | SEC filing · Form 8-K | +2.04% | -5.32% | |
| Form 8-K Telomir Pharmaceuticals, For: Apr 12 | SEC filing · Form 8-K | -2.05% | -4.74% | |
| Form 10-K Telomir Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.37% | +0.37% |
Keep exploring
More TELO: earnings → · analyst actions → · TELO overview →